Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
J Pept Sci ; 17(3): 192-9, 2011 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-21308875

RESUMO

In order to investigate the relationship between the primary structure of Orpotrin, a vasoactive peptide previously isolated from the freshwater stingray Potamotrygon gr. orbignyi, and its microcirculatory effects, three Orpotrin analogs were synthesized. The analogs have a truncated N-terminal with a His residue deletion and two substituted amino acid residues, where one Nle is substituted for one internal Lys residue and the third analog has a substitution of a Pro for an Ala (Orp-desH(1) , Orp-Nle and Orp-Pro/Ala, respectively). Only Orp-desH(1) could induce a lower vasoconstriction effect compared with the natural Orpotrin, indicating that besides the N-terminal, the positive charge of Lys and the Pro residues located at the center of the amino acid chain is crucial for this vasoconstriction effect. Importantly, the suggestions made with bioactive peptides were based on the molecular modeling and dynamics of peptides, the presence of key amino acids and shared activity in microcirculation, characterized by intravital microscopy. Moreover, this study has demonstrated that even subtle changes in the primary structure of Orpotrin alter the biological effects of this native peptide significantly, which could be of interest for biotechnological applications.


Assuntos
Venenos de Peixe/química , Venenos de Peixe/farmacologia , Peptídeos/farmacologia , Sequência de Aminoácidos , Animais , Leucócitos/efeitos dos fármacos , Camundongos , Microcirculação/efeitos dos fármacos , Microscopia , Dados de Sequência Molecular , Peptídeos/síntese química , Peptídeos/química , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz , Relação Estrutura-Atividade
2.
J Pain Symptom Manage ; 60(4): 782-789, 2020 10.
Artigo em Inglês | MEDLINE | ID: mdl-32360991

RESUMO

CONTEXT: Racial and ethnic disparities in end-of-life care are well documented among adults with advanced cancer. OBJECTIVES: To examine the extent to which communication and care differ by race and ethnicity among children with advanced cancer. METHODS: We conducted a prospective cohort study at nine pediatric cancer centers enrolling 95 parents (42% racial/ethnic minorities) of children with poor prognosis cancer (relapsed/refractory high-risk neuroblastoma). Parents were surveyed about whether prognosis was discussed; likelihood of cure; intent of current treatment; and primary goal of care. Medical records were used to identify high-intensity medical care since the most recent recurrence. Logistic regression evaluated differences between white non-Hispanic and minority (black, Hispanic, and Asian/other race) parents. RESULTS: About 26% of parents recognized the child's low likelihood of cure. Minority parents were less likely to recognize the poor prognosis (odds ratio [OR] = 0.19; 95% CI = 0.06-0.63; P = 0.006) and the fact that current treatment was unlikely to offer cure (OR = 0.07; 95% CI = 0.02-0.27; P < 0.0001). Children of minority parents were more likely to experience high-intensity medical care (OR = 3.01; 95% CI = 1.29-7.02; P = 0.01). After adjustment for understanding of prognosis, race/ethnicity was no longer associated with high-intensity medical care (adjusted odds ratio = 2.14; 95% CI = 0.84-5.46; P = 0.11), although power to detect an association was limited. CONCLUSION: Parental understanding of prognosis is limited across racial and ethnic groups; racial and ethnic minorities are disproportionately affected. Perhaps as a result, minority children experience higher rates of high-intensity medical care. Work to improve prognostic understanding should include focused work to meet needs of minority populations.


Assuntos
Hispânico ou Latino , Neoplasias , Adulto , Negro ou Afro-Americano , Criança , Comunicação , Humanos , Neoplasias/terapia , Estudos Prospectivos , População Branca
3.
BMC Bioinformatics ; 9: 492, 2008 Nov 25.
Artigo em Inglês | MEDLINE | ID: mdl-19032768

RESUMO

BACKGROUND: The Structural Descriptor Database (SDDB) is a web-based tool that predicts the function of proteins and functional site positions based on the structural properties of related protein families. Structural alignments and functional residues of a known protein set (defined as the training set) are used to build special Hidden Markov Models (HMM) called HMM descriptors. SDDB uses previously calculated and stored HMM descriptors for predicting active sites, binding residues, and protein function. The database integrates biologically relevant data filtered from several databases such as PDB, PDBSUM, CSA and SCOP. It accepts queries in fasta format and predicts functional residue positions, protein-ligand interactions, and protein function, based on the SCOP database. RESULTS: To assess the SDDB performance, we used different data sets. The Trypsion-like Serine protease data set assessed how well SDDB predicts functional sites when curated data is available. The SCOP family data set was used to analyze SDDB performance by using training data extracted from PDBSUM (binding sites) and from CSA (active sites). The ATP-binding experiment was used to compare our approach with the most current method. For all evaluations, significant improvements were obtained with SDDB. CONCLUSION: SDDB performed better when trusty training data was available. SDDB worked better in predicting active sites rather than binding sites because the former are more conserved than the latter. Nevertheless, by using our prediction method we obtained results with precision above 70%.


Assuntos
Armazenamento e Recuperação da Informação/métodos , Proteínas/química , Proteínas/fisiologia , Proteômica/métodos , Análise de Sequência de Proteína/métodos , Software , Algoritmos , Inteligência Artificial , Sítios de Ligação/genética , Sítios de Ligação/fisiologia , Domínio Catalítico/genética , Domínio Catalítico/fisiologia , Bases de Dados de Proteínas , Internet , Reconhecimento Automatizado de Padrão , Conformação Proteica , Proteínas/genética , Relação Estrutura-Atividade
4.
Vet Parasitol ; 184(2-4): 238-47, 2012 Mar 23.
Artigo em Inglês | MEDLINE | ID: mdl-22001703

RESUMO

The present paper presents the partial characterization of a family I inorganic pyrophosphatase from the hard tick Rhipicephalus (Boophilus) microplus (BmPPase). The BmPPase gene was cloned from the tick embryo and sequenced. The deduced amino acid sequence shared high similarity with other eukaryotic PPases, on the other hand, BmPPase presented some cysteine residues non-conserved in other groups. This pyrophosphatase is inhibited by Ca(2+), and the inhibition is antagonized by Mg(2+), suggesting that the balance between free Ca(2+) and free Mg(2+) in the eggs could be involved in BmPPase activity control. We observed that the BmPPase transcripts are present in the fat body, midgut and ovary of ticks, in two developmental stages (partially and fully engorged females). However, higher transcription amounts were found in ovary from fully engorged females. BmPPase activity was considerably abolished by the thiol reagent dithionitrobenzoic acid (DTNB), suggesting that cysteine residues are exposed in its structure. Therefore, these cysteine residues play a critical role in the structural stability of BmPPase. Molecular dynamics simulation analysis indicates that BmPPase is the first Family I PPase that could promote disulfide bonds between cysteine residues 138-339 and 167-295. Finally, we believe that these cysteine residues exposed in the BmPPase structure can play an important controlling role regarding enzyme activity, which would be an interesting mechanism of redox control. The results presented here also indicate that this enzyme can be involved in embryogenesis of this arthropod, and may be useful as a target in the development of new tick control strategies.


Assuntos
Pirofosfatase Inorgânica/genética , Rhipicephalus/enzimologia , Rhipicephalus/genética , Sequência de Aminoácidos , Animais , Bovinos , Ácido Ditionitrobenzoico/farmacologia , Ativação Enzimática/efeitos dos fármacos , Inibidores Enzimáticos/farmacologia , Feminino , Perfilação da Expressão Gênica , Regulação Enzimológica da Expressão Gênica , Pirofosfatase Inorgânica/química , Modelos Moleculares , Dados de Sequência Molecular , Filogenia , Estrutura Terciária de Proteína , Rhipicephalus/classificação , Rhipicephalus/embriologia , Alinhamento de Sequência
5.
Peptides ; 30(12): 2191-9, 2009 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-19682520

RESUMO

Brazilian freshwater stingrays, Potamotrygon gr. orbigyni, are relatively common in the middle-western regions of Brazil, where they are considered an important public health threat. In order to identify some of their naturally occurring toxin peptides available in very low amounts, we combine analytical protocols such as reversed-phase high-performance liquid chromatography (RP-HPLC), followed by a biological microcirculatory screening and mass spectrometry analysis. Using this approach, one bioactive peptide was identified and characterized, and two analogues were synthesized. The natural peptide named Porflan has the primary structure ESIVRPPPVEAKVEETPE (MW 2006.09 Da) and has no similarity with any bioactive peptide or protein found in public data banks. Bioassay protocols characterized peptides as presenting potent activity in a microcirculatory environment. The primary sequences and bioassay results, including interactions with the membrane phospholipids, suggest that these toxins are a new class of fish toxins, directly involved in the inflammatory processes of a stingray sting.


Assuntos
Venenos de Peixe/metabolismo , Peptídeos/química , Peptídeos/metabolismo , Rajidae/metabolismo , Sequência de Aminoácidos , Animais , Cromatografia Líquida de Alta Pressão , Venenos de Peixe/química , Espectrometria de Massas , Simulação de Dinâmica Molecular , Dados de Sequência Molecular , Espectrometria de Massas em Tandem
6.
Funct Plant Biol ; 32(11): 1045-1055, 2005 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-32689200

RESUMO

Aluminum (Al) toxicity induces changes in the expression of several genes, some of which are involved in plant responses to oxidative stress. Using mRNA differential display, we identified a maize Al-inducible cDNA encoding a glutathione S-transferase (GST). The gene was named GST27.2 owing to its homology to the maize gene GST27, which is known to be induced by xenobiotics. GST27.2 is present in the maize genome as a single copy and analysis of its expression pattern revealed that the gene is expressed mainly in the root tip. Expression was up-regulated in response to various Al and Cd concentrations in both Al-tolerant and Al-sensitive maize lines. Consistent with its role in plants, phylogenetic analysis of theta-type GSTs revealed that GST27.2 belongs to a group of proteins that respond to different stresses. Finally, structural analysis of the polypeptide chain indicates that the two amino acids that differ between GST27.2 and GST27 (E102K and P123L) could be responsible for alterations in activity and / or specificity. Together, these results suggest that GST27.2 may play an important part in plant defenses against Al toxicity.

7.
Biochem Biophys Res Commun ; 329(2): 457-64, 2005 Apr 08.
Artigo em Inglês | MEDLINE | ID: mdl-15737609

RESUMO

Disintegrins are among the most potent antagonists of several integrins. A cDNA encoding a novel disintegrin, bothrostatin, was cloned from a Bothrops jararaca cDNA library. The precursor of bothrostatin contains a pro, a metalloproteinase, and an RGD-disintegrin domain. The disintegrin domain expressed in Escherichia coli showed high inhibitory activity on collagen-induced platelet aggregation (IC(50) of 12nM), and thus it can be used as a useful tool for studies of integrin-ligand interaction. Furthermore, we used the comparative modeling approach to obtain a model of the 3D structure of bothrostatin. Our results suggest that bothrostatin adopts a globular, closed structure in solution. The RGD motif is exposed to the solution by the loop formed by residues 45-59 and is very close to the C-terminal domain forming a finger-like structure. The proximity of the RGD loop and the C-terminal residues, which is maintained by the Cys47-Cys66 bond, suggests that the C-terminal residues are involved in the ability of bothrostatin to interact with its ligands.


Assuntos
Bothrops/metabolismo , Venenos de Crotalídeos/biossíntese , Venenos de Crotalídeos/química , Desintegrinas/biossíntese , Desintegrinas/química , Metaloproteases/biossíntese , Metaloproteases/química , Modelos Moleculares , Engenharia de Proteínas/métodos , Sequência de Aminoácidos , Animais , Plaquetas/efeitos dos fármacos , Bothrops/genética , Células Cultivadas , Clonagem Molecular/métodos , Simulação por Computador , Venenos de Crotalídeos/análise , Desintegrinas/genética , Desintegrinas/farmacologia , Escherichia coli/genética , Escherichia coli/metabolismo , Humanos , Metaloproteases/genética , Metaloproteases/farmacologia , Dados de Sequência Molecular , Peso Molecular , Agregação Plaquetária/efeitos dos fármacos , Relação Estrutura-Atividade
8.
Biochem Biophys Res Commun ; 308(2): 219-26, 2003 Aug 22.
Artigo em Inglês | MEDLINE | ID: mdl-12901857

RESUMO

Angiotensin I-converting enzyme (ACE) is a dipeptidyl carboxypeptidase which converts angiotensin I into the vasopressor peptide angiotensin II and also inactivates the hypotensive peptide bradykinin, playing an important role in blood pressure regulation. The present work describes the molecular modeling of the N-terminal human somatic ACE in complex with the inhibitor lisinopril, identifying the residues involved in the inhibitor-binding pocket. The obtained results identify differences in the lisinopril lysine moiety-binding residues for N- and C-terminals of sACE domains and an important carboxy-terminal proline hydrophobic accommodations mediated by the aromatic ring of Tyr532 and Tyr1128 residues, respectively. The present model will be useful for the development of a new inhibitor family based on the natural BPP peptides and derivatives, or even to improve the binding capacities and the domain specificity of the already known inhibitors.


Assuntos
Inibidores da Enzima Conversora de Angiotensina/metabolismo , Lisinopril/metabolismo , Peptidil Dipeptidase A/química , Peptidil Dipeptidase A/metabolismo , Sequência de Aminoácidos , Domínio Catalítico/genética , Cloretos/metabolismo , Humanos , Técnicas In Vitro , Modelos Moleculares , Dados de Sequência Molecular , Peptidil Dipeptidase A/genética , Estrutura Terciária de Proteína , Homologia de Sequência de Aminoácidos , Especificidade por Substrato
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA